Abstract
AIMS--To evaluate antibodies directed against CD31 (JC70/A) and CD34 (QBEND/10 and anti-HPCA-1) more extensively in Kaposi sarcoma; to assess their value in routine diagnosis; and to compare them with the traditional endothelial cell markers Ulex europaeus agglutinin 1 (UEA-1) and factor VIII related antigen. METHODS--Twenty four cases of Kaposi sarcoma were studied retrospectively. All specimens had been fixed in formalin and embedded in paraffin wax. The antibodies were applied using the Streptavidin biotin technique in all cases except for UEA-1, for which an indirect two stage method was used involving peroxidase conjugated anti-ulex as the secondary antibody. RESULTS--Tumours were classified into those showing angiomatoid or lymphangiomatoid elements and spindle cell lesions. Universal labelling of all lesions and virtually all elements within lesions was seen with the anti-CD34 antibodies QBEND/10 and HPCA-1. Labelling of spindle cells was less consistent with JC70/A but both markers were superior to the traditional endothelial cell markers UEA-1 and factor VIII related antigen. CONCLUSIONS--These data confirm that Kaposi sarcoma is a tumour of endothelial cell origin. They shed further light on the histogenesis of this complex tumour and demonstrate that immunostaining for CD34 and CD31 can be used as an aid to diagnosis in routinely processed tissue.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gange R. W., Jones E. W. Lymphangioma-like Kaposi's sarcoma. A report of three cases. Br J Dermatol. 1979 Mar;100(3):327–334. doi: 10.1111/j.1365-2133.1979.tb06207.x. [DOI] [PubMed] [Google Scholar]
- Holden C. A., Spaull J., Williams R., Spry C. J., Jones R. R., Jones E. W. The detection of endothelial cell antigens in cutaneous tissue using methacarn and periodate lysine paraformaldehyde fixation. J Immunol Methods. 1986 Jul 11;91(1):45–52. doi: 10.1016/0022-1759(86)90100-6. [DOI] [PubMed] [Google Scholar]
- Jones R. R., Spaull J., Spry C., Jones E. W. Histogenesis of Kaposi's sarcoma in patients with and without acquired immune deficiency syndrome (AIDS). J Clin Pathol. 1986 Jul;39(7):742–749. doi: 10.1136/jcp.39.7.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leader M., Collins M., Patel J., Henry K. Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma. Histopathology. 1986 Nov;10(11):1153–1162. doi: 10.1111/j.1365-2559.1986.tb02555.x. [DOI] [PubMed] [Google Scholar]
- Nickoloff B. J. PECAM-1 (CD31) is expressed on proliferating endothelial cells, stromal spindle-shaped cells, and dermal dendrocytes in Kaposi's sarcoma. Arch Dermatol. 1993 Feb;129(2):250–251. [PubMed] [Google Scholar]
- Parums D. V., Cordell J. L., Micklem K., Heryet A. R., Gatter K. C., Mason D. Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990 Sep;43(9):752–757. doi: 10.1136/jcp.43.9.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ramani P., Bradley N. J., Fletcher C. D. QBEND/10, a new monoclonal antibody to endothelium: assessment of its diagnostic utility in paraffin sections. Histopathology. 1990 Sep;17(3):237–242. doi: 10.1111/j.1365-2559.1990.tb00713.x. [DOI] [PubMed] [Google Scholar]
- Sankey E. A., More L., Dhillon A. P. QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma. J Pathol. 1990 Jul;161(3):267–271. doi: 10.1002/path.1711610315. [DOI] [PubMed] [Google Scholar]
- Suster S., Wong T. Y. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations. Am J Dermatopathol. 1994 Aug;16(4):355–363. doi: 10.1097/00000372-199408000-00001. [DOI] [PubMed] [Google Scholar]